| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f01fcb93b6b5b9193708488549bc630
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a876c40215eb0200fe6603416aeb03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e71b552168c3d6c1b1eef16b4e6404f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b1c9538dfe15e93a4dcde2a6cb93857 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-585 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate |
2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44041a8b3eb1e20f4de650367161bf76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6a5f9ad468aa0783676189cea140877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b32b48e158a3e57e2da89fb400dcac |
| publicationDate |
2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03020242-A9 |
| titleOfInvention |
Sustained release preparations |
| abstract |
The invention relates to oral pharmaceutical preparations that comprise a pharmacologically active drug bound to small particles of an ion-exchange resin. Drug-resin complexes are coated with an aqueous based diffusion barrier comprising a water-permeable, film forming polymer that is relatively insoluble in gastrointestinal fluids thereby providing a controllable sustained release of drug under conditions encountered in the gastrointestinal tract. At least some of the barrier coated drug-resin particles may be coated with an enteric coating to provide a tailored release profile. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9180100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549989-B2 |
| priorityDate |
2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |